MNI: UK NOV FINAL MANUF PMI 48.0 (FLASH 48.6); OCT 49.9

MNI: EUROZONE NOV FINAL MANUF PMI 45.2 (FLASH 45.2); OCT 46.0

MNI: GERMANY NOV FINAL MANUF PMI 43.0 (FLASH 43.2); OCT 43.0

MNI: PBOC Net Drains CNY216 Bln via OMO Monday

MNI: PBOC Sets Yuan Parity Lower At 7.1865 Mon; -1.50% Y/Y

MNI: China CFETS Yuan Index Up 0.01% In Week of Nov 29

MNI: FRANCE NOV FINAL MANUF PMI 43.1 (FLASH 43.2); OCT 44.5

MNI: ITALY NOV MANUF PMI 44.5 (FCST 46.0); OCT 46.9

MNI: SPAIN NOV MANUF PMI 53.1 (FCST 54.0); OCT 54.5

AUSTRALIA: 2025 Election Outcome Looking More Uncertain According To Newspoll

MNI EXCLUSIVE: German Turmoil Dashes EU's Joint-Funding Hopes -Officials

© 1982-2024 MNI. All rights reserved.
Terms | Privacy
Log Out
Free Trial

Bayer: 1Q24 Preview

HEALTHCARE

Bayer (BAYNGR: Baa2 neg/BBB/BBB): 1Q24 Preview


Bayer reports tomorrow ahead of the open. Currently they are provisioning for EUR 5.7bn ($6.3bn) for RoundUp litigation. This is 59% of their total ‘Other Provisions’ Current and Non-Current items. The market will be looking for any significant change in that figure. The company has won 11/16 recent cases and managed to reduce payout by 90% in several otherwise negative results.

  • The other main risk for Bayer is the eventual loss of exclusivity on their two major drugs Eylea and Xarelto which contribute 40% of their total Pharma revenue (7.3bn / 18bn). The market will want to see further progress on sales in Nubeqa and Kerendi and any news on Elinzanetant.
  • Bayer have cut their dividend to the legal minimum which saves around EUR 2bn per year. The company is also making significant cuts in bureaucracy to save a further EUR 2bn by end 2026. Any talk of splitting the company has been shelved for the intermediate term.
  • Revenue EUR 14bn expected.
  • Nubeqa sales 285m analysts estimate.
  • Adj EBITDA EUR 4.2bn
Credit BulletsBulletHomepagemarkets-real-timeCredit
Credit BulletsBulletHomepagemarkets-real-timeCredit

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.